Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene

Neuromuscul Disord. 2020 Apr;30(4):336-339. doi: 10.1016/j.nmd.2020.02.012. Epub 2020 Feb 24.


Congenital myasthenic syndromes (CMS) are a group of inherited disorders caused by mutations in genes encoding proteins essential for neuromuscular transmission. CMS is characterized by fatigable muscle weakness with onset at birth or in early childhood; rarely, symptoms may present later. The most frequently involved proteins are choline acetyltransferase, the endplate species of acetylcholinesterase and the acetylcholine receptor subunits. Defects in the cholinergic receptor nicotinic delta subunit (CHRND) are a rare cause for CMS but they should be considered in patients with a severe, early onset disease, with respiratory distress. We describe two sisters, clinically and genetically diagnosed with CMS, carrying two heteroallelic variants in the CHRND gene: c.730C>T; p.(Arg244Cys) and c.1304T>C; p.(Leu435Pro). The first variant has already been described yet no clinical relevance has been proved; the second one, is a novel variant documented here for the first time. These two cases expand the clinical spectrum of CMS linked to CHRND mutations.

Keywords: AChR delta subunit; Children; Lethal phenotype; Precocious onset.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Alleles
  • Female
  • Humans
  • Infant
  • Mutation
  • Myasthenic Syndromes, Congenital / genetics*
  • Myasthenic Syndromes, Congenital / physiopathology*
  • Pedigree
  • Receptors, Cholinergic / genetics*
  • Severity of Illness Index
  • Siblings


  • CHRND protein, human
  • Receptors, Cholinergic